Differential regulation of protein expression in response to polyunsaturated fatty acids in the liver of apoE-knockout mice and in HepG2 cells

Chun-Ying Huang, Wei‐Ming Chen, Yeou‐Guang Tsay, Shu‐Chen Hsieh, Yun Lin, Wen‐Jane Lee, Wayne Huey‐Herng Sheu, An-Na ChiangJournal of Biomedical Science 2015 · DOI

TL;DR

This study investigates how polyunsaturated fatty acids (PUFAs), particularly omega-3s, affect protein expression in the liver of mice and human liver cells. They found that PUFAs significantly alter liver protein profiles and that omega-3 PUFAs can suppress inflammatory responses by modulating key signaling pathways, offering new insights into their health benefits.

What Problem Does This Paper Address?

The liver is a central hub for metabolism and plays a critical role in maintaining health. Polyunsaturated fatty acids (PUFAs), essential nutrients, are known to have various physiological functions, including reducing inflammation and improving cardiovascular health. However, the precise molecular mechanisms by which PUFAs influence liver function, especially concerning protein expression and inflammatory signaling, remain poorly understood. This paper aims to bridge this knowledge gap by examining how different PUFAs impact the liver's proteome and how omega-3 PUFAs specifically modulate inflammatory responses in liver cells.

Methods

The researchers employed a two-pronged approach:

  • Proteomics in Mice: They used 2-dimensional gel electrophoresis (2-D GE) coupled with mass spectrometry (MS) to analyze changes in protein expression in the livers of apoE-knockout mice fed different PUFAs (DHA, EPA, AA, and LA). This is a standard, albeit labor-intensive, method for identifying and quantifying thousands of proteins in a sample.
  • Cellular Assays in HepG2 Cells: To investigate the anti-inflammatory effects of omega-3 PUFAs (DHA and EPA), they used the human hepatoma cell line HepG2. They employed:
  • MTT assay to assess cell viability and ensure PUFAs weren't toxic at the tested concentrations.
  • Western blotting to measure protein secretion (specifically C-reactive protein, CRP) and the levels of key signaling proteins (NF-κB subunits p65 and p50, and STAT3).
  • RT-PCR and real-time quantitative PCR to measure CRP mRNA expression.
  • Reporter gene assays (using a luciferase construct) to examine the effect of PUFAs on CRP gene transcription.

Datasets

  • Mouse Liver Proteome: The study generated a dataset of differentially expressed hepatic proteins from apoE-knockout mice treated with four different PUFAs. This dataset is presented in Table 2 of the paper, listing 93 up-regulated and 12 down-regulated proteins.
  • HepG2 Cell Signaling Data: The paper presents quantitative data on CRP secretion, CRP mRNA levels, NF-κB subunit expression, and STAT3 phosphorylation in HepG2 cells under various PUFA and cytokine treatments.

Key Insights and Ideas

  • PUFAs are potent modulators of liver proteome: The study revealed that even short-term PUFA feeding significantly alters the expression of a substantial number of liver proteins, suggesting a broad impact on hepatic function.
  • Omega-3s (DHA/EPA) are key anti-inflammatories: While all PUFAs affected protein profiles, the n-3 PUFAs (DHA and EPA) stood out for their ability to suppress inflammatory markers in HepG2 cells.
  • Differential regulation of inflammatory pathways: The paper highlights that n-3 PUFAs don't just broadly suppress inflammation; they target specific signaling cascades. DHA and EPA differentially affect NF-κB and STAT3 pathways, suggesting distinct mechanisms of action.
  • STAT3 phosphorylation is a key target: The suppression of STAT3 phosphorylation at Tyr705 by DHA and EPA is a critical finding, as STAT3 is a major player in inflammatory responses. The involvement of a protein tyrosine phosphatase (PTPase) in DHA's effect on STAT3 adds another layer of complexity.
  • CRP is a central mediator: The study focuses on C-reactive protein (CRP) as a key inflammatory marker, demonstrating that n-3 PUFAs can significantly reduce its production at both the mRNA and protein levels.

Key Results

  • In vivo: 93 hepatic proteins were significantly up-regulated and 12 were down-regulated in apoE-KO mice treated with four different PUFAs. DHA and EPA led to more up-regulated proteins.
  • In vitro (HepG2 cells):
    • DHA and EPA reduced CRP secretion by over 50% compared to IL-1β/IL-6 stimulation.
  • DHA and EPA inhibited CRP mRNA induction by more than half.
  • DHA and EPA significantly suppressed nuclear NF-κB p65 and p50 subunit expression in response to IL-6.
  • DHA and EPA significantly suppressed nuclear STAT3 phosphorylation at Tyr705.
  • DHA's effect on STAT3 phosphorylation was reversed by a PTPase inhibitor, suggesting PTPase involvement.
  • IL-6 alone induced CRP promoter activity by 4.6-fold, and IL-1β/IL-6 synergistically induced it by 7.9-fold. DHA and EPA reduced this IL-6-induced promoter activity.

Limitations and Future Work

  • In vivo relevance of specific proteins: While the proteomic analysis identified many differentially expressed proteins, the paper acknowledges that their precise physiological significance and impact on health require further investigation.
  • Mechanistic details of n-6 PUFAs: The study focused on the anti-inflammatory effects of n-3 PUFAs. The role and mechanisms of n-6 PUFAs (AA and LA) in inflammation warrant further exploration.
  • PTPase specificity: While a broad PTPase inhibitor reversed DHA's effect on STAT3, identifying the specific PTPase involved would be a valuable next step.
  • In vivo validation of cellular findings: The study proposes a model for n-3 PUFA action in HepG2 cells. Further research is needed to confirm these mechanisms in vivo in the apoE-KO mouse model.
  • Long-term effects: The study primarily focused on short-term effects. Investigating the long-term consequences of PUFA supplementation on liver health and disease prevention would be beneficial.

Summary updated

Abstract

This study indicates that PUFAs induced changes in the hepatic protein profile in vivo. Furthermore, n-3 PUFAs exert their anti-inflammatory properties through differential molecular mechanisms in hepatic cells. These results provide novel information regarding the roles of PUFAs in the liver at the tissue and cellular levels.
BibTeX
@article{huang2015differential,
  author = {Chun-Ying Huang and Wei‐Ming Chen and Yeou‐Guang Tsay and Shu‐Chen Hsieh and Yun Lin and Wen‐Jane Lee and Wayne Huey‐Herng Sheu and An-Na Chiang},
  title = {{Differential regulation of protein expression in response to polyunsaturated fatty acids in the liver of apoE-knockout mice and in HepG2 cells}},
  journal = {Journal of Biomedical Science},
  year = {2015},
  doi = {10.1186/s12929-015-0118-2},
}
Figure